Renew on pathological mechanism of glutamate and its receptors after cerebral ischemia

Chinese Pharmacological Bulletin

Volumn 28, Issue 6, 2012, Pages 747-750

  Song, Wen Ting ^a   Xu, Li ^a   Liu, Jian Xun ^a  

^a XIYUAN HOSPITAL   (China)

Author keywords

Cerebral ischemia; Excitotoxicity; Glutamate; Glutamate receptor; Glutamate transporter; Neurons

Indexed keywords

GLUTAMATE RECEPTOR; GLUTAMIC ACID;

BRAIN ISCHEMIA; EXCITOTOXICITY; GENE EXPRESSION; NEUROPATHOLOGY; NEUROTRANSMITTER RELEASE; REVIEW; SIGNAL TRANSDUCTION;

EID: 84864992992     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1001-1978.2012.06.003     Document Type: Review

References (26)

1. Coyle J T, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders[J]. Science,1993,262(5134):689-95. (Pubitemid 23350687)
2. Mei H S, Wang Y L. The mechanisms of glutamate release in cerebral ischemia[J]. Chin Pharmacol Bull,2005,21(4):393-6.
3. Grewer C, Gameiro A, Zhang Z, et al. Glutamate forward and reverse transport: from molecular mechanism to transporter-mediated release after ischemia[J]. IUBMB life,2008,60(9):609-19.
4. Verma R, Mishra V, Sasmal D, et al. Pharmacological evaluation of glutamate transporter 1 (GLT-1) mediated neuroprotection following cerebral ischemia/reperfusion injury[J]. Eur J Pharmacol,2010,638(1-3):65-71.
5. Ketheeswaranathan P, Turner N A, Spary E J, et al. Changes in glutamate transporter expression in mouse forebrain areas following focal ischemia[J]. Brain Res,2011,18(1418):93-103.
6. Harvey B K, Airavaara M, Hinzman J, et al. Targeted over-expression of glutamate transporter 1 (GLT-1) reduces ischemic brain injury in a rat model of stroke[J]. PloS ONE,2011,6(8):e22135-41.
7. Shen Y, He P, Fan Y Y, et al. Carnosine protects against permanent cerebral ischemia in histidine decarboxylase knockout mice by reducing glutamate excitotoxicity[J]. Free Rad Biol Med,2010,48(5):727-35.
8. Jabaudon D, Scanziani M, Gahwiler BH, et al. Acute decrease in net glutamate uptake during energy deprivation[J]. Proceed Nat Acad Sci Unit Stat Am,2000,97(10):5610-5. (Pubitemid 30313766)
9. Rossi D J, Oshima T, Attwell D. Glutamate release in severe brain ischaemia is mainly by reversed uptake[J]. Nature,2000,403(1):316-21. (Pubitemid 30062388)
10. Shirasaki Y, Sugimura M, Sato T. Bromocriptine, an ergot alkaloid, inhibits excitatory amino acid release mediated by glutamate transporter reversal[J]. Eur J Pharmacol,2010,643(1):48-57.
11. Mehta S L, Manhas N, Raghubir R. Molecular targets in cerebral ischemia for developing novel therapeutics[J]. Brain Res Rev,2007,54(1):34-66. (Pubitemid 46498164)
12. Beckman J S. Beckman T W, Chen J, et al. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide[J]. Proceedings Nat Acad Sci Unit Stat Am,1990,87(4):1620- 4.
13. Aarts M, Liu Y, Liu L, et al. Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions[J]. Science,2002,298(5594): 846-50. (Pubitemid 35231541)
14. Sattler R, Xiong Z, Lu W Y, et al. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein[J]. Science,1999,284(5421):1845-8.
15. Horn J, Hann R J, Vermeulen M, et al. Very early nimodipine use in stroke (VENUS): A randomized, double-blind, placebo-controlled trial[J]. Stroke,2001,32(2):461-5. (Pubitemid 32155235)
16. Horn J, Limburg M. Calcium antagonists for acute ischemic stroke. Cochrane database of systematic reviews[DB]. 2000(2):CD001928.
17. Colleoni S, Jensen A A, Landucci E, et al. Neuroprotective effects of the novel glutamate transporter inhibitor (-)-3-hydroxy-4,5,6,6a-tetrahydro-3aH- pyrrolo[3, 4-d]-isoxazole-4-carboxylic acid, which preferentially inhibits reverse transport (glutamate release) compared with glutamate reuptake[J]. J Pharmacol Exper Therap,2008,326(2):646-56.
18. Simon R, Shiraishi K. N-methyl-D-aspartate antagonist reduces stroke size and regional glucose metabolism[J]. Ann Neurol,1990,27(6):606-11. (Pubitemid 20177407)
19. Davis S M, Lees K R, Albers G W, et al. Selfotel in acute ischemic stroke: possible neurotoxic effects of an NMDA antagonist[J]. Stroke,2000,31(2):347-54. (Pubitemid 30078164)
20. Ginsberg M D. Neuroprotection for ischemic stroke: past, present and future[J]. Neuropharmacology,2008,55(3):363-89.
21. Tang W, Sun X, Fang J S, et al. Flavonoids from Radix Scutellariae as potential stroke therapeutic agents by targeting the second postsynaptic density 95 (PSD-95)/disc large/zonula occludens-1 (PDZ) domain of PSD-95[J]. Phytomedicine,2004,11(4):277-84. (Pubitemid 38657456)
22. Wen W, Wang W, Zhang M. Targeting PDZ domain proteins for treating NMDA receptor-mediated excitotoxicity[J]. Curr Top Med Chem,2006,6(7):711-21.
23. Taoufik E, Probert L. Ischemic neuronal damage[J]. Cur Pharm Des,2008,14(33):3565-73.
24. Zhu L, Wu J, Liao H, et al. Antagonistic effects of extract from leaves of Gingko biloba on glutamate neurotoxicity[J]. Acta Pharmacol Sin,1997,18(4):344-7. (Pubitemid 27314488)
25. Wang H, Qiu X Y, Yang L S, Liao S S. Effects of Ginkgo biloba extract in different cerebral temperature on the oxygen free radical concentration in rat focal cerebral ischemia[J]. China J Mod Med,2010,20(15):2276-8.
26. Bastianetto S, Zheng W H, Quirion R. The Ginkgo biloba extract (EGB 761) protects and rescues hippocampal cells against nitric oxide induced toxicity: involvement of its flavonoid constituents and protein kinase C[J]. J Neurochem,2000,74(10):2268-77. (Pubitemid 30314201)